US FDA approves expanded use of Mirum's liver disease drug
The U.S Food and Drug Administration has approved the expanded use of Mirum Pharmaceuticals' oral drug to treat itching caused by a liver disorder in patients aged five years and older, the company said on Wednesday.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.